Honoring U.S. Senator Jon Kyl
As Arizona celebrated its Centennial, AZBio honored Arizona Senator Jon Kyl for his dedication and service to both our industry and the people of our state with the 2012 AZBio Centennial Award.Senator Kyl is serving his third and final term in the U.S. Senate after previously serving for eight years in the U.S. House of Representatives. He was elected unanimously by his colleagues in 2008 to serve as Republican Whip, the second-highest position in Senate Republican leadership.
Enjoy Senator Kyl's remarks about Arizona's Bioindustry and the introduction by Fritz Bittenbender of the Biotechnology Industry Association (BIO)
W.L. Gore and Associaties, Inc. the 2013 Arizona Bioscience Company of the Year
Company Presentation - Kulira Technologies
Kulira Technologies is an advanced biomedical engineering company that designs solutions for surgical oncology using state-of-the-art biomaterials.
President and CEO, Xenia Kachur, shares where they've been and where they are going at AZBio Expo 2013.
Finding a Solution for Valley Fever
David Larwood, CEO, Valley Fever Solutions
Bringing new compounds and diagnostics to help detect and treat Valley Fever. VFS has received good support from government grants, and collaborates closely with the Valley Fever Center for Excellence, vfce.arizona.edu. We are moving towards Phase II trials in humans of Nikkomycin-Z, a compound that shows great promise in treating humans or animals infected with Valley Fever.
Cancer Genomics: the future of personalized medicine
2012 Bioscience Leader of the Year, Robert Penny, MD, PhD shares the history of the Cancer Genome Atlas Project and a look forward at the future of personalized medicine.
CBR - 20 Years of Cord Blood Research
Cord blood stem cells have been used to treat more than 80 diseases, from leukemias and anemias to immune and metabolic disorders. Today, even more treatment options are being evaluated in cutting-edge, FDA-regulated clinical trials. This growing number of potential uses means more medical options for your family later.
Arizona Pioneer Thomas M. Grogan, MD
Thomas M. Grogan, M.D., Founder of Ventana and SVP, Medical Affairs of Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, receives the AZBio Pioneer Award for Lifetime Achievement at the 2013 AZBio Awards on October 10, 2013.
Dr. Grogan was a pathologist and professor at the University of Arizona when in the mid 1980’s he and a small team set out to challenge the limitations of the then current standards and processes for cancer pathology. What was to become the company’s first digital pathology instrument evolved from Grogan’s notes on a yellow pad into the BenchMark IHC/ISH staining platforms. Under Grogan’s leadership, Ventana was founded in 1987, went public in 1996, and was acquired by Roche for $3.4 billion in 2008. Over the last 25 years, Ventana has grown to become a global leader in developing and manufacturing tissue-based diagnostic instruments and tests focused on the detection of cancer. Ventana employees continue to pursue the same deeply rooted mission of innovating diagnostic testing and enabling personalized healthcare to improve the lives of all patients afflicted with cancer worldwide.
Dr. Grogan has made it his personal mission to make life better for the millions of patients who battle cancer each day. His passion and dedication are infectious and has spread across the company that he and his team built. Through their efforts they have revolutionized the field of cancer diagnostics and are pioneering new roads in the field of personalized healthcare.”